title: Higher Adalimumab Drug Levels Are Associated with Mucosal Healing in Patients with Crohn's Disease.
authors.affiliation: Center for Inflammatory Bowel Diseases, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA kpapamic@bidmc.harvard.edu.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Papamichael
authors.affiliation: Center for Inflammatory Bowel Diseases, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
authors.forename: Adam S
authors.initials: AS
authors.lastname: Cheifetz
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease; D006801:Humans; D007413:Intestinal Mucosa; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab